Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection
Diana Bilton, Isabelle Fajac, Tacjana Pressler, John P. Clancy, Dorota Sands, Predrag Minić, Marco Cipolli, Ivanka Galeva, Amparó Solé, Alexandra L. Quittner, Zhanna Jumadilova, Monika Ciesielska, Michael W. Konstan
Topics & Concepts
MedicineTolerabilityCystic fibrosisInternal medicineDiscontinuationExacerbationAdverse effectTobramycinSputumAmikacinSurgeryPseudomonas aeruginosaAntibioticsBacteriaMicrobiologyGeneticsPathologyBiologyTuberculosisCystic Fibrosis Research AdvancesInhalation and Respiratory Drug DeliveryNosocomial Infections in ICU